Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03487692 · ClinicalTrials.gov registry record · NA

Medical Care, Education, Social Support, And Goal-setting to Empower Self-management for Diabetes

A NA study of Type 2 Diabetes Mellitus, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
265
Enrollment target
1
Study location

NCT03487692 is a NA study of Type 2 Diabetes Mellitus that has completed, run by University of Chicago. The registered enrollment target is 265 participants, below the 2,746-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03487692, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
265 participants
Enrollment target
1
Study location

Study Summary

Diabetes group visits, shared appointments where patients receive self-management education in a group setting and have a medical visit, are a promising way to deliver high quality diabetes care. Group visits can improve glycemic control and decrease healthcare utilization. To date, no studies have systematically implemented a diabetes group visit intervention in a network of U.S. community health centers. The University of Chicago is partnering with Midwest Clinicians' Network (MWCN), a member organization of 130 health centers across ten Midwestern states. Approximately half of all Federally Qualified Health Centers in this region are affiliated with MWCN. The objectives of the study are \[1\] providers and staff at 20 health centers will have the requisite knowledge, skills, and motivation to implement a diabetes group visit plus text messaging intervention at their sites; \[2\] changes in diabetes processes of care; knowledge, attitudes, and skills for diabetes self-management; clinical outcomes; and health care utilization for patients participating in the diabetes group visit program will be evaluated; and \[3\] the diabetes group visit program will be available for dissemination among and use by health centers and healthcare providers at the local, state, regional, and national levels.

Conditions Studied

Type 2 Diabetes Mellitus

Interventions

  • OTHER Diabetes MESSAGES Program
  • OTHER Diabetes MESSAGES Program (second trial)

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 265 participants
Start Date 2018-10-18
Est. Completion 2022-06-30
Phase NA

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03487692

The ClinicalTrials.gov registry entry for NCT03487692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,746-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (90% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Diabetes MESSAGES Program is the first listed.

NCT03487692 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03487692 about?

NCT03487692 is a clinical study titled "Medical Care, Education, Social Support, And Goal-setting to Empower Self-management for Diabetes". Diabetes group visits, shared appointments where patients receive self-management education in a group setting and have a medical visit, are a promising way to deliver high quality diabetes care. Group visits can improve glycemic control and decrease healthcare utilization. To date, no studies have ...

What is the current status of trial NCT03487692?

This trial is currently completed. It is a NA study. The enrollment target is 265 participants. The study started on 2018-10-18. Estimated completion is 2022-06-30.

What conditions does trial NCT03487692 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT03487692?

The interventions under investigation include: Diabetes MESSAGES Program (OTHER), Diabetes MESSAGES Program (second trial) (OTHER).

Who is sponsoring clinical trial NCT03487692?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03487692 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes Mellitus

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.